ArticleMolecular psychiatry2025
Towards clinical subtypes in schizophrenia: integrating cognitive, functional, and digital phenotyping assessments.
Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heterogeneity in the clinical presentation of schizophrenia impairs both proper and preventative care. The digital phenotyping data gathered from an international multi-site cohort study in people with schizophrenia (SZ) offers a novel opportunity to explore clinically meaningful subtypes in the context of clinical, functional, and cognitive data. Using a set of behavioral features derived from smartphone digital phenotyping, clinical assessment of symptoms including PANSS, clinical assessment of cognition with BACS, and clinical assessment of functioning with the social functioning assessments over the target period of twelve months, we found that the international cohort of 74 patients were categorized into three well-defined clusters that suggest clinically actionable targets from differential correlations in each. Namely, the identified clusters seemed to share phenotypic traits with the affective psychosis with more severe symptomatic presentation, a non-affective SZ with functional impairment, and a higher functioning non-affective SZ cluster. Partial correlation analysis further highlighted the emergence of different features per cluster, where anxiety symptoms were most notable for one group, whereas psychotic symptoms were most notable for the other two. Importantly, we showcase an analysis pipeline that transparently addresses challenges of missing data and potential skew so that this research methodology can be applied to future prospective validation studies. This study hopes to build a foundation for future digital phenotyping clustering work by scaling up to new sites, and populations to uncover the nature and extent of heterogeneity in schizophrenia.
Indexed as
Identifiers
40394283What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.